Literature DB >> 16595526

Effect of antibiotic treatment of subclinical mastitis on human immunodeficiency virus type 1 RNA in human milk.

V Nussenblatt1, N Kumwenda, V Lema, T Quinn, M C Neville, R Broadhead, T E Taha, R D Semba.   

Abstract

Although subclinical mastitis is associated with increased HIV load in breast milk, it is not known whether empirical treatment with antibiotics will reduce breast milk HIV load. We examined the effect of antibiotic treatment for subclinical mastitis on HIV load in breast milk. Seventy-five HIV-infected post-partum women in Malawi with subclinical mastitis were treated with oral amoxicillin/clavulanic acid and were followed between 1 and 24 weeks later. Breastmilk HIV-1 load and sodium concentration were measured and microbiological studies were performed at presentation. At 1 week (n = 34), the proportion of women with elevated breast milk leukocyte counts decreased significantly to 41.2% (p < 0.0001) and there was a nonsignificant increase in breast milk HIV-1 RNA load (p = 0.9264) and sodium concentration (p = 0.08) in the affected breast. At 4 to 12 weeks (n = 63), breast milk HIV-1 RNA load and sodium concentration decreased significantly (p < 0.05) and 17.5% had elevated breast milk leukocyte counts. Treatment with amoxicillin/clavulanic acid was associated with a significant decrease in inflammation of the breast, but breast milk HIV load remained elevated despite a significant decrease from baseline. These findings have important implications regarding how mothers should be counselled on safety of resuming breastfeeding after resolution of subclinical mastitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595526     DOI: 10.1093/tropej/fml011

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  6 in total

1.  Exclusive breastfeeding, maternal HIV disease, and the risk of clinical breast pathology in HIV-infected, breastfeeding women.

Authors:  Katherine Semrau; Louise Kuhn; Daniel R Brooks; Howard Cabral; Moses Sinkala; Chipepo Kankasa; Donald M Thea; Grace M Aldrovandi
Journal:  Am J Obstet Gynecol       Date:  2011-06-15       Impact factor: 8.661

2.  Subclinical mastitis occurs frequently in association with dramatic changes in inflammatory/anti-inflammatory breast milk components.

Authors:  Edouard Tuaillon; Johanes Viljoen; Pierre Dujols; Gilles Cambonie; Pierre-Alain Rubbo; Nicolas Nagot; Ruth M Bland; Stéphanie Badiou; Marie-Louise Newell; Philippe Van de Perre
Journal:  Pediatr Res       Date:  2016-11-04       Impact factor: 3.756

3.  Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis.

Authors:  Soren Gantt; Jacquelyn Carlsson; Avinash K Shetty; Kristy D Seidel; Xuan Qin; Junior Mutsvangwa; Georgina Musingwini; Godfrey Woelk; Lynn S Zijenah; David A Katzenstein; Lisa M Frenkel
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

Review 4.  The role of co-infections in mother-to-child transmission of HIV.

Authors:  Caroline C King; Sascha R Ellington; Athena P Kourtis
Journal:  Curr HIV Res       Date:  2013-01       Impact factor: 1.581

Review 5.  The Mammary Microenvironment in Mastitis in Humans, Dairy Ruminants, Rabbits and Rodents: A One Health Focus.

Authors:  Katherine Hughes; Christine J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-04-28       Impact factor: 2.673

6.  Recurrent Severe Subclinical Mastitis and the Risk of HIV Transmission Through Breastfeeding.

Authors:  David Gatsinzi Rutagwera; Jean-Pierre Molès; Chipepo Kankasa; Mwiya Mwiya; Edouard Tuaillon; Marianne Peries; Nicolas Nagot; Philippe Van de Perre; Thorkild Tylleskär
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.